Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Polyclonal Antibody

Anti-STING1/TMEM173 Polyclonal Antibody

Catalog #:   PHJ16701 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: ELISA, IHC, WB
Accession: Q86WV6
Overview

Catalog No.

PHJ16701

Species reactivity

Human

Host species

Rabbit

Isotype

IgG

Clonality

Polyclonal

Immunogen

E. coli - derived recombinant Human STING1/TMEM173 (Leu139-Ser379).

Tested applications

ELISA: 1:4000-1:8000, IHC: 1:50-1:100, WB: 1:1000-1:4000

Target

STING1,Stimulator of interferon genes protein,Endoplasmic reticulum interferon stimulator,Transmembrane protein 173,ERIS,hSTING,TMEM173,Mediator of IRF3 activation,MITA,hMITA

Purification

Purified by antigen affinity column.

Accession

Q86WV6

Applications

ELISA, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Data Image
  • Western blot
    Various lysates were subjected to SDS PAGE followed by western blot with STING1 / TMEM173 antibody (PHJ16701) at 0.8μg/ml.

    Lane 1: THP1 cell lysate

    Second Ab: Goat Anti-Rabbit IgG H&L Polyclonal antibody, HRP (PTB96431) at 0.1 μg/mL.

    Predict MW: 42 kDa
    Observed MW: 42 kDa
  • Immunocytochemistry/ Immunofluorescence
    STING1 / TMEM173 in 293T Cell Line.
    The 293T cells were fixed with 4% paraformaldehyde (20 min), and then blocked with 5% goat serum for 1h. And the cells were incubated for 2h at 37°C with STING1 / TMEM173 (PHJ16701) at 16 μg/ml. The section was then incubated with Goat Anti-Rabbit IgG (Alexa Fluor-488) preabsorbed at 1/100 dilution (Shown in green) for 1 hour at room temperature.Nuclear DNA was labelled with DAPI (shown in blue).
  • Western Blot
    Recombinant Protein lysates were subjected to SDS PAGE followed by western blot with STING1/TMEM173 antibody (PHJ16701) at 1 µg/ml.

    Lane 1: Recombinant Protein

    Second Ab: Goat Anti-Rabbit IgG H&L Polyclonal antibody, HRP (PTB96431) at 0.1 μg/mL.

    Predict MW: 29 kDa
    Observed MW: 29 kDa
References

A Multi-Threshold Micelle Improves Tumor Accumulation and STING Immunotherapy., PMID:40439216

Nanoimmunomodulation of the Aβ-STING feedback machinery in microglia for Alzheimer's disease treatment., PMID:40434641

Reprogramming tumor-associated macrophages using STING or TLR agonists: a promising strategy to enhance immunotherapy in hormone-dependent cancers., PMID:40379270

[Buzhong Yiqi Decoction alleviates immune injury of autoimmune thyroiditis in NOD.H-2~(h4)mice via c GAS-STING signaling pathway]., PMID:40350879

The emerging concept of ANCA-associated vasculitis related to inborn errors of immunity., PMID:40294837

[Effects of lipopolysaccharide-activated interferon gene stimulator signaling on periodontal ligament cells]., PMID:40268534

STING agonist-based ER-targeting molecules boost antigen cross-presentation., PMID:40140567

Dual-modality immune nano-activator harnessing Mn2⁺ and quercetin to potentiate the cGAS-STING pathway for advanced cancer metalloimmunotherapy., PMID:40128784

Regulation and Function of the cGAS-STING Pathway: Mechanisms, Post-Translational Modifications, and Therapeutic Potential in Immunotherapy., PMID:40098909

Enhanced therapeutic efficacy of anti-PD-1 blockade by targeting LAMP2A inhibits lysosomal degradation of STING and TBK1., PMID:40083918

PCK1 inhibits cGAS-STING activation by consumption of GTP to promote tumor immune evasion., PMID:40048154

ADSL-generated fumarate binds and inhibits STING to promote tumour immune evasion., PMID:40033100

XMT-2056, a HER2-Directed STING Agonist Antibody-Drug Conjugate, Induces Innate Antitumor Immune Responses by Acting on Cancer Cells and Tumor-Resident Immune Cells., PMID:40029253

STING activation improves T-cell-engaging immunotherapy for acute myeloid leukemia., PMID:40009483

Sustained Interferon Signature Suppression With Anifrolumab in a Patient With STING-Associated Vasculopathy with Onset in Infancy Refractory to JAK Inhibitor and Dazukibart Therapy., PMID:40007227

TAX1BP1-dependent autophagic degradation of STING1 impairs anti-tumor immunity., PMID:40000606

Zinc-copper bimetallic nanoplatforms trigger photothermal-amplified cuproptosis and cGAS-STING activation for enhancing triple-negative breast cancer immunotherapy., PMID:39994712

Inhibitors of soluble epoxide hydrolase and cGAS/STING repair defects in amyloid-β clearance underlying vascular complications of Alzheimer's disease., PMID:39962970

STING activation and overcoming the challenges associated with STING agonists using ADC (antibody-drug conjugate) and other delivery systems., PMID:39922441

Selective STING Activation in Intratumoral Myeloid Cells via CCR2-Directed Antibody-Drug Conjugate TAK-500., PMID:39918395

Chemotherapy boosts anti-angiogenic and anti-PD-1 combination therapy through activation of cCAS-STING pathway in colon cancer., PMID:39904029

Immune checkpoint inhibitors mediate myocarditis by promoting macrophage polarization via cGAS/STING pathway., PMID:39884185

Intratumoral or Subcutaneous MK-2118, a Noncyclic Dinucleotide STING Agonist, with or without Pembrolizumab, for Advanced or Metastatic Solid Tumors or Lymphomas., PMID:39846804

Activating the cGAS-STING Pathway by Manganese-Based Nanoparticles Combined with Platinum-Based Nanoparticles for Enhanced Ovarian Cancer Immunotherapy., PMID:39846241

Open-label, phase Ia study of STING agonist BI 1703880 plus ezabenlimab for patients with advanced solid tumors., PMID:39817655

Personalized Nanovaccine Based on STING-Activating Nanocarrier for Robust Cancer Immunotherapy., PMID:39817337

STING Agonist VB-85247 Induces Durable Antitumor Immune Responses by Intravesical Administration in a Non-Muscle-Invasive Bladder Cancer., PMID:39700406

Tissue factor promotes TREX1 protein stability to evade cGAS-STING innate immune response in pancreatic ductal adenocarcinoma., PMID:39658648

Role of STING Deficiency in Amelioration of Mouse Models of Lupus and Atherosclerosis., PMID:39605244

Urease-powered nanomotor containing STING agonist for bladder cancer immunotherapy., PMID:39548120

Bendamustine-rituximab elicits dual tumoricidal and immunomodulatory responses via cGAS-STING activation in diffuse large B-cell lymphoma., PMID:39521616

Bidirectional regulation of the cGAS-STING pathway in the immunosuppressive tumor microenvironment and its association with immunotherapy., PMID:39464890

Targeting STING signaling for the optimal cancer immunotherapy., PMID:39450170

Immunomodulatory effects of trastuzumab deruxtecan through the cGAS-STING pathway in gastric cancer cells., PMID:39449023

Robust and Sustained STING Pathway Activation via Hydrogel-Based In Situ Vaccination for Cancer Immunotherapy., PMID:39405469

Intratumoral STING agonist reverses immune evasion in PD-(L)1-refractory Merkel cell carcinoma: mechanistic insights from detailed biomarker analyses., PMID:39401968

Alzheimer's disease-linked risk alleles elevate microglial cGAS-associated senescence and neurodegeneration in a tauopathy model., PMID:39353433

DKN-01 Suppresses Gastric Cancer Progression Through Activating cGAS-STING Pathway to Block Macrophage M2 Polarization., PMID:39352454

Loss of Annexin A1 in macrophages restrains efferocytosis and remodels immune microenvironment in pancreatic cancer by activating the cGAS/STING pathway., PMID:39237260

Cannabidiol Enhances Atezolizumab Efficacy by Upregulating PD-L1 Expression via the cGAS-STING Pathway in Triple-Negative Breast Cancer Cells., PMID:39226389

Microglial cGAS-STING signaling underlies glaucoma pathogenesis., PMID:39190350

Napabucasin deactivates STAT3 and promotes mitoxantrone-mediated cGAS-STING activation for hepatocellular carcinoma chemo-immunotherapy., PMID:39180916

Metal-Phenolic Vehicles Potentiate Cycle-Cascade Activation of Pyroptosis and cGAS-STING Pathway for Tumor Immunotherapy., PMID:39155444

Overcome the challenge for intratumoral injection of STING agonist for pancreatic cancer by systemic administration., PMID:39113096

Circulating cell-free DNA promotes inflammation in dermatomyositis patients with anti-NXP2 antibodies  via the cGAS/STING pathway., PMID:39110532

Targeting a STING agonist to perivascular macrophages in prostate tumors delays resistance to androgen deprivation therapy., PMID:39060021

Tetrandrine activates STING/TBK1/IRF3 pathway to potentiate anti-PD-1 immunotherapy efficacy in non-small cell lung cancer., PMID:39059614

A polymeric nanoplatform enhances the cGAS-STING pathway in macrophages to potentiate phagocytosis for cancer immunotherapy., PMID:39038546

Activation of autoreactive lymphocytes in the lung by radioresistant cells expressing a STING gain-of-function mutation., PMID:39024563

A High Immune-Related Index with the Suppression of cGAS-STING Pathway is a Key Determinant to Herceptin Resistance in HER2+ Breast Cancer., PMID:38993569

Datasheet
$ 170
Product specifications
50 μg 170 100 μg 280

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-STING1/TMEM173 Polyclonal Antibody [PHJ16701]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only